Viewing Study NCT07061535


Ignite Creation Date: 2025-12-24 @ 10:04 PM
Ignite Modification Date: 2025-12-30 @ 2:51 PM
Study NCT ID: NCT07061535
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-07-11
First Post: 2025-07-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module